Professor Des Richardson visits and delivers two keynote talks at the School of Allied Health Sciences (SAH) International Conference, Walailak University, Thailand

Professor Des Richardson delivered two keynote talks on March 25th, 2023, at the School of Allied Health Sciences (SAH) International Conference 2023 held at Walailak University in Thailand. The talks focused on cutting-edge research in the design and development of novel anti-cancer drugs, with a particular emphasis on inhibiting metastasis and overcoming drug resistance.

School of Allied Health Sciences (SAH) International Conference 2023

In the first talk, titled "Design and Development of Novel Anti-Cancer Drugs that Inhibit Metastasis and Overcome Drug Resistance," Professor Richardson presented his team's research into the development of new therapies that target metastasis, which is the leading cause of cancer mortality. The talk explored the latest advances in the field, including the development of drugs that target cancer cells' ability to spread to other parts of the body. This highlighted the potential of this research, which could lead to groundbreaking new treatments for cancer patients.

In his second talk, titled "The Metastasis Suppressor, NDRG1, Down-Regulates EGFR via a Lysosomal Mechanism by Up-Regulating the Tumor Suppressor, Mitogen-Inducible Gene 6 (MIG6)," Professor Richardson delved deeper into the molecular mechanisms behind the spread of cancer cells. He explained how his team's research has identified the metastasis suppressor NDRG1 as a key player in regulating the activity of the epidermal growth factor receptor (EGFR), a protein that is often overexpressed in cancer cells. By understanding how NDRG1 works, Professor Richardson's team has developed new approaches to targeting EGFR, which could help overcome drug resistance in cancer patients.

Both talks highlighted the importance of understanding the molecular mechanisms underlying cancer progression and developing new strategies to target cancer cells. Professor Richardson's research is contributing to the development of new anti-cancer drugs that can improve patient outcomes and help reduce the global burden of cancer.

Overall, Professor Richardson's visit to Walailak University was a valuable opportunity for students, researchers, and clinicians to learn from a renowned expert in cancer research and to gain insights into the latest developments in the field. The talks were informative and engaging, and the audience left with a deeper understanding of the challenges and opportunities in cancer research.